%0 Editorial
%T The expanding horizon of anti-IL-36 therapy.
%A Heymann WR
%J J Am Acad Dermatol
%V 90
%N 4
%D 2024 Apr 1
%M 38296196
%F 15.487
%R 10.1016/j.jaad.2024.01.034